ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

DCPC Board Cool Toward Moving Centers, Other Programs to New Division; Issue To NCAB May 26

May 15, 1987

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

ACS Encourages Research Proposals Psychosocial Aspects Of Cancer

March 26, 1982

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994

Minna To Direct Howard Simmons Cancer Center At Texas Southwestern; ‘Major Loss’ for NCI

March 1, 1991